Zinc supplementation and chronic pelvic pain syndrome

Evaluation of the effect of zinc supplementation in treatment of patients with chronic pelvic pain syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210614051574N12

Enrollment

Registered

2022-06-22

Start date

2022-07-22

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pelvic pain syndrome. Pelvic and perineal pain

Interventions

Intervention 1: Intervention group: Patients in this group, in addition to routine medications, treated with zinc supplements (made by Abian Company, containing 41.4 mg of zinc sulfate) will take dail

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18-65 years Diagnosis of chronic pelvic pain syndrome by a urologist Absence of underlying disease Free and informed written consent

Exclusion criteria

Exclusion criteria: Failure to take medication regularly Drug intolerance Taking zinc supplements during the last 3 months Tendency to leave during the study

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before and after two weeks and one month after interventions. Method of measurement: Visual analog scale.;Chronic pelvic pain. Timepoint: Before and after two weeks and one month after interventions. Method of measurement: Chronic Prostatitis Symptom Index (NIH-CPSI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehruz Karkhanei

Hamedan University of Medical Sciences

bk13472000@yahoo.com+98 81 3838 0706

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026